Enteral Infant Formulas: A Narrative Review of Historical Evolution, Nutritional Composition, and Clinical Use in Pediatrics

TL;DR

This review explores the history, types, and uses of infant formulas for children who cannot be breastfed or follow normal feeding methods.

Contribution

The paper provides a comprehensive narrative review of enteral infant formulas, emphasizing their clinical applications and nutritional composition.

Findings

Enteral formulas include polymeric, hydrolyzed, elemental, and blenderized types, each suited for specific clinical needs.

Formulas are used for conditions like cow’s milk allergy, Crohn’s disease, and cystic fibrosis.

Regulatory frameworks in the US and Europe classify these formulas as medical foods with distinct requirements.

Abstract

This narrative review aims to describe the evolution, classification, nutritional composition, and clinical applications of enteral infant formulas, with an emphasis on pediatric patients who are unable to be breastfed or follow conventional feeding methods. The primary objective is to analyze the different types of formulas available - polymeric, hydrolyzed, elemental, and blenderized - and their indications based on clinical scenarios and specific patient needs.

The methodology used was a non-systematic narrative review. Relevant scientific literature was selected through a targeted search of databases such as PubMed, Scopus, ScienceDirect, and Google Scholar, including publications from the last 20 years in both English and Spanish. Key search terms included “enteral nutrition,” “infant formula,” “nutritional therapy,” and “pediatric enteral feeding.”

The article traces the historical development of infant nutrition, from breastfeeding and wet nursing to modern enteral formulas. It explains the macronutrient composition of each formula type, their preparation methods, palatability, osmolality, and caloric density. Clinical considerations and recommended formulas for specific diseases - such as obesity, cow’s milk allergy, Crohn’s disease, eosinophilic esophagitis, necrotizing enterocolitis, short bowel syndrome, and cystic fibrosis - are discussed in detail.

Additionally, the review outlines the regulatory context in the United States and Europe, noting that these products are classified as medical foods and not pharmaceuticals, and are thus subject to distinct safety, composition, and labeling requirements.

The review concludes that although breastfeeding remains the gold standard in infant nutrition, enteral formulas are indispensable in many clinical situations. Future research is expected to focus on the development of more targeted, functional, and personalized formulas to address the needs of vulnerable pediatric populations.

Figures